GENFLOW BIOSCIENCES PLC
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Genflow Biosciences PLC is a UK-based biotech firm dedicated to discovering and advancing new therapeutic approaches to halt or slow the ageing process for longer, healthier lives.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-24 08:00 |
Earnings Release
Clinical Readiness Acceleration
|
English | 17.7 KB | |
| 2025-07-17 08:00 |
Capital/Financing Update
Genflow Confirms Progression of Grant
|
English | 18.0 KB | |
| 2025-06-12 11:16 |
Post-Annual General Meeting Information
Result of AGM
|
English | 30.5 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
Genflow Signs Master Services Agreement
|
English | 13.4 KB | |
| 2025-05-15 08:00 |
Regulatory News Service
Key SIRT6 Patent Application
|
English | 12.3 KB | |
| 2025-05-12 11:50 |
Major Shareholding Notification
Holding(s) in Company
|
English | 68.7 KB | |
| 2025-05-07 19:07 |
Annual Report (ESEF)
Annual financial statements 2024
|
English | 493.4 KB | |
| 2025-05-07 19:07 |
Annual Report
Annual financial statements 2024
|
English | 1.5 MB | |
| 2025-03-28 08:10 |
Major Shareholding Notification
Holding in Company
|
English | 23.0 KB | |
| 2025-03-28 08:00 |
Director's Dealing
Director Dealings
|
English | 25.2 KB | |
| 2025-03-26 08:00 |
Share Issue/Capital Change
Institutional Investment
|
English | 19.6 KB | |
| 2025-02-20 08:00 |
Regulatory News Service
Advancements in SIRT6 Variant Patent Application
|
English | 19.4 KB | |
| 2025-01-13 08:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.3 KB | |
| 2025-01-13 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.4 KB | |
| 2025-01-06 08:00 |
Business and Financial Review
2024 Highlights
|
English | 18.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |